SHIRLEY, NY, May 28, 2026 /24-7PressRelease/ — Creative Biolabs announces expanded lipid-based drug delivery services for researchers developing mRNA therapeutics, siRNA drugs, protein biologics, vaccines, and gene delivery systems. The platform combines custom liposome and lipid nanoparticle (LNP) formulation with particle characterization, stability evaluation, and scalable manufacturing support.
Nucleic acids and biologics often face delivery barriers, including payload instability, enzymatic degradation, limited bioavailability, and inefficient cellular uptake. Creative Biolabs develops formulations designed to support payload protection, controlled release, endosomal escape, and optimized particle performance across discovery and translational development.
LNP Formulation Services for mRNA and siRNA Delivery
LNP formulation services involve the design and optimization of lipid nanoparticles to encapsulate and deliver genetic payloads such as mRNA, siRNA, plasmid DNA, and gene-editing components. Creative Biolabs supports ionizable lipid screening, microfluidic formulation, buffer optimization, particle size control, PDI analysis, zeta potential measurement, encapsulation efficiency testing, and stability studies. These services may help researchers improve formulation consistency and intracellular delivery while supporting process scale-up.
Liposome Formulation Services for Proteins, Peptides, and Small Molecules
Liposomes are lipid vesicles that can carry hydrophilic and hydrophobic payloads. Compared with LNPs, which are widely used for nucleic acid delivery, liposomes are often selected for small molecules, proteins, peptides, and controlled-release applications. Creative Biolabs provides lipid composition optimization, surface modification, release profile evaluation, and formulation screening to support payload-specific development needs.
Applications and Development Support
The lipid-based delivery platform can be applied to mRNA vaccines, siRNA therapeutics, gene therapy, oncology drug delivery, protein and peptide delivery, and biologics formulation. In addition to formulation design, Creative Biolabs offers analytical characterization and scale-up support to help clients move from early feasibility studies toward preclinical development.
“Efficient delivery remains a key challenge for next-generation therapeutics,” said a senior scientist at Creative Biolabs. “Our lipid-based formulation services are designed to help researchers select suitable lipid systems, evaluate critical quality attributes, and optimize delivery performance based on payload type.”
FAQ
Q1: Can LNPs deliver both mRNA and siRNA?
A1: Yes. LNPs can be optimized for different nucleic acid payloads, including mRNA, siRNA, plasmid DNA, and gene-editing cargoes.
Q2: What payloads can liposomes encapsulate?
A2: Liposomes can be designed for hydrophilic drugs, hydrophobic drugs, proteins, peptides, and other biologically active molecules.
Researchers developing mRNA therapeutics, siRNA drugs, protein biologics, vaccines, or gene delivery systems can contact Creative Biolabs for payload-specific lipid formulation consultation. To learn more, visit: https://www.creative-biolabs.com/lipid-based-delivery/.
About Creative Biolabs
Creative Biolabs is a biotechnology service provider specializing in lipid-based drug delivery, nanomedicine development, and biologics formulation solutions for global research and pharmaceutical clients.
—
For the original version of this press release, please visit 24-7PressRelease.com here
Legal Disclaimer: The content on this page is syndicated from independent third-party providers. Kyrion Media makes no warranties or representations regarding the accuracy, completeness, legality, or reliability of the information, including text, images, videos, or licenses. If you are affiliated with this content or have any complaints, copyright concerns, or requests for removal, please contact us at retract@kyrionmedia.com with the specific URL of the content in question. We will review and address valid requests promptly.
